Katsuhisa Ohgi

Katsuhisa Ohgi

Auto-generated profile, based on publicly available information

Katsuhisa Ohgi

Division of Hepato‐Biliary‐Pancreatic Surgery Shizuoka Cancer Center Shizuoka Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
STShunsuke Tamura
Shunsuke Tamura
RARyo Ashida
Ryo Ashida
TSTeiichi Sugiura
Teiichi Sugiura
YOYukiyasu Okamura
Yukiyasu Okamura
TITakaaki Ito
Takaaki Ito
KUKatsuhiko Uesaka
Katsuhiko Uesaka

1 July 2021 in BJS Open
Verified
Journal Article
Open access
PDF file
TST Sugiura
T Sugiura
KUK Uesaka
K Uesaka
YOY Okamura
Y Okamura
TIT Ito
T Ito
YYYusuke Yamamoto
Yusuke Yamamoto
KAK Asakura
K Asakura
Hepatectomy with vascular resection (VR) for perihilar cholangiocarcinoma (PHCC) is a challenging procedure. However, only a few reports on this procedure have been published and its clinical significance has not been fully evaluated. Patients undergoing surgical resection for PHCC from 2002–2017 were studied. The surgical outcomes of VR and non-VR groups were compared. Some 238 patients were included. VR was performed in 85 patients. The resected vessels were hepatic artery alone (31 patients), portal vein alone (37 patients) or both (17 patients). The morbidity rates were almost the same in the VR (49.4 per cent) and non-VR (43.8 per cent) groups (P = 0.404). The mortality rates of VR (3.5 per cent) and non-VR (3.3 per cent) were also comparable (P > 0.999). The median survival time (MST) was 45 months in the non-VR group and 36 months in VR group (P = 0.124). Among patients in whom tumour involvement was suspected on preoperative imaging and whose carbohydrate antigen 19-9 (CA19-9) value was 37 U/ml or less, MST in the VR group was significantly longer than that in the non-VR group (50 versus 34 months, P = 0.017). In contrast, when the CA19-9 value was greater than 37 U/ml, MST of the VR and non-VR groups was comparable (28 versus 29 months, P = 0.520). Hepatectomy with VR for PHCC can be performed in a highly specialized hepatobiliary centre with equivalent short- and long-term outcomes to hepatectomy without VR.

26 June 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
KOKatsuhisa Ohgi
Katsuhisa Ohgi
TSTeiichi Sugiura
Teiichi Sugiura
YYYusuke Yamamoto
Yusuke Yamamoto
YOYukiyasu Okamura
Yukiyasu Okamura
TITakaaki Ito
Takaaki Ito
KUKatsuhiko Uesaka
Katsuhiko Uesaka

16 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TITaisuke Imamura
Taisuke Imamura
RARyo Ashida
Ryo Ashida
KOKeiichi Ohshima
Keiichi Ohshima
KUKatsuhiko Uesaka
Katsuhiko Uesaka
TSTeiichi Sugiura
Teiichi Sugiura
KYKen Yamaguchi
Ken Yamaguchi
In pancreatic cancer (PC), Tumor mutation burden (TMB) has been reported to be lower than in other cancers, with its clinical significance remaining unclear. We analyzed the dataset of whole-exome sequencing and gene expression profiling of 93 resected PC cases. The median TMB was 0.24. The TMB was classified as High (≥ 5.0), Low (< 5.0, ≥ 1.0), or Ultra-low (< 1.0). Nineteen samples (20%) were classified as TMB-low, and 74 (80%) were classified as TMB-ultra-low; no samples were TMB-high. TMB-ultra-low PC had significantly fewer borderline resectable lesions (P = 0.028) and fewer adenosquamous carcinomas (P = 0.003) than TBM-low PC. Furthermore, the TMB-ultra-low PC showed significantly lower detection rates of driver mutations and copy number variations. Microsatellite instability was not significantly correlated with the TMB status. The TMB-ultra-low PC had a significantly better prognosis than TBM-low PC (P = 0.023). A multivariate analysis identified TMB-ultra-low PC as an independent favorable prognostic factor (hazard ratio, 2.11; P = 0.019). A gene expression analysis showed that TMB-ultra-low PC was associated with reduced TP53 inactivation (P = 0.003) and reduced chromosomal instability (P = 0.001) compared to TBM-low PC. TMB-ultra-low PC had specific gene expression signatures and a better prognosis than TMB-low PC.

1 March 2019 in Surgery
Verified
Journal Article
Closed access
SSShusei Sano
Shusei Sano
TSTeiichi Sugiura
Teiichi Sugiura
IKIchiro Kawamura
Ichiro Kawamura
YOYukiyasu Okamura
Yukiyasu Okamura
TITakaaki Ito
Takaaki Ito
KUKatsuhiko Uesaka
Katsuhiko Uesaka

6 July 2017 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
KOKatsuhisa Ohgi
Katsuhisa Ohgi
YYYusuke Yamamoto
Yusuke Yamamoto
TSTeiichi Sugiura
Teiichi Sugiura
YOYukiyasu Okamura
Yukiyasu Okamura
TITakaaki Ito
Takaaki Ito
KUKatsuhiko Uesaka
Katsuhiko Uesaka